Search for: "Parallel Productions, Inc." Results 601 - 620 of 1,002
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2012, 11:57 am
  In sum, the Third Circuit held that MAOs have an equal and parallel private right of action (as traditional fee for services Medicare) to sue primary payers where those payers fail to provide for payment or appropriate reimbursement to MAOs. [read post]
2 Jul 2012, 11:57 am
  In sum, the Third Circuit held that MAOs have an equal and parallel private right of action (as traditional fee for services Medicare) to sue primary payers where those payers fail to provide for payment or appropriate reimbursement to MAOs. [read post]
27 Jun 2012, 3:58 pm
Originally called Sun Microsystems Inc v M-Tech Data Ltd and another (noted by the IPKat here), the case of Oracle America Inc (formerly Sun Microsystems Inc) v M-Tech Data Ltd and Lichtenstein was marked out by the IPKat as a thunderously bad decision when the Court of Appeal reversed the decision of Kitchin J at [2010] EWCA Civ 997. [read post]
27 Jun 2012, 11:33 am by Francis Pileggi
Allergan, Inc., a Delaware corporation which develops and commercializes specialty pharmaceuticals, biologics, and medical devices, specifically Botox Therapeutic, entered into the settlement after admitting that they illegally promoted off-label uses of their popular drug. [read post]
14 Jun 2012, 1:10 am by Scott A. McKeown
These issues were recently explored in Kimberly-Clark Worldwide Inc., v First Quality Baby products et al. [read post]
31 May 2012, 3:36 am by Laura Anil (laura.anil@olswang.com)
  The case concerns a trademark infringement claim brought by Oracle America, Inc against a parallel importer of its hardware, M-Tech Data Ltd, in relation to which the High Court held that M-Tech’s defences (based on principles of EU competition law) had no reasonable prospect of success. [read post]
14 May 2012, 9:30 pm
 The leading case appears to be the Fourth Circuit's 1999 ruling in Food Lion Inc. v. [read post]
10 May 2012, 12:31 pm by WIMS
Policies to address permanent changes in oil prices could take two broad approaches parallel to those above: Increasing domestic production of oil or oil substitutes or Reducing the consumption of oil by, for example, increasing fuel-efficiency standards or encouraging the development of alternative transportation options that use less, or no, oil. [read post]
4 May 2012, 10:00 am by Lucas A. Ferrara, Esq.
Elelyso is manufactured and distributed by New York City-based Pfizer Inc., under license from Protalix BioTherapeutics Inc. [read post]
2 May 2012, 9:30 pm by Abigail Slater
 Under Twombly, in order to successfully plead a conspiracy, “allegations of parallel conduct” must “be placed in a context that raises a suggestion of a preceding agreement, not merely parallel conduct that could just as well be independent action. [read post]
26 Apr 2012, 7:48 am
Effectively, this means medical device makers face absolutely no accountability for making and selling products they know or should know will hurt patients who trust them, which presents obvious safety problems. [read post]